Does Meta want to compete with Nvidia? Here's a sign of its growing ambition in chips.

The tech giant (META) is acquiring chip startup Rivos Inc. to build on its in-house chip development, a person familiar with the matter confirmed with MarketWatch. Bloomberg News first reported the ...

Nubank Applies for U.S. National Bank Charter

Nubank said it has applied for a national bank charter with the U.S. Office of the Comptroller of the Currency. The Brazil-based digital financial services platform said Tuesday a U.S. national bank ...

Qualcomm promises it can be an AI winner. But does it know what Nvidia and Intel do?

Qualcomm is asking investors to believe in three simultaneous bets: that AI PCs will drive meaningful market and revenue expansion; edge AI will create new recurring revenue streams, and that the ...

The S&P 500 and Nasdaq are set for their best September in over 15 years. Can the momentum last through year-end?

Instead, the S&P 500 SPX and the Nasdaq Composite COMP on Tuesday were on pace to close out their best September in 15 years - a surprise twist that now has investors wondering if the rally could keep ...

Merck Up Over 6%, on Pace for Largest Percent Increase Since October 2021 — Data Talk

Merck Up Over 6%, on Pace for Largest Percent Increase Since October 2021 — Data Talk Merck & Co., Inc. (MRK) is currently at $83.54, up $4.96 or 6.31% --Would be highest close since Sept. 11, 2025, ...

Apple destroyed shareholder value with this move. It's been a hidden drag on the stock.

Developing an AI "killer app" has been a point of weakness for Apple shares this year, as they have lagged behind their "Magnificent Seven" peers. The stock is up just 1.4% in 2025.

The boom of ad-supported streaming is starting to look a bit like old-school television

Top subscription streaming services, like Netflix (NFLX), Walt Disney Co.'s (DIS) Disney+ and Amazon.com Inc.'s (AMZN) Prime Video, saw 1% growth over the same time frame. Others - like Paramount+, ...

Pfizer found a way to boost its ailing stock - agree with Trump on drug pricing

Pfizer's stock surged after CEO Albert Bourla announced an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty.

Why this veteran investor sees gold hitting $7,000 by the end of Trump's term

But the metal's rally may still have years to go. Holmes sees gold climbing to $7,000 an ounce, potentially, by the end of President Donald Trump's second term as president, which ends in January 2029 ...

Trump's son-in-law Kushner only did smallish deals. Now he's part of the biggest buyout ever.

Jared Kushner has found a role in the $55 billion Electronic Arts megadeal. His involvement could ease its passage through Washington. Jared Kushner, shown here at the Future Investment Initiative ...

Pfizer Best Performer in the S&P 500 So Far Today — Data Talk

Pfizer Inc. (PFE) is currently at $25.10, up $1.26 or 5.26% --Would be highest close since Aug. 25, 2025, when it closed at $25.14 --On pace for largest percent increase since May 1, 2024, when it ...

Pfizer Reaches Agreement with Trump Administration to Lower Drug Costs in U.S., Invest $70 Billion — Update

Pfizer struck a deal with the Trump administration to lower its U.S. medicine prices and invest an additional $70 billion in onshore manufacturing in exchange for shelter from tariffs.